A1 Refereed original research article in a scientific journal

Prevalence of Schizophrenia in Idiopathic Normal Pressure Hydrocephalus




AuthorsVasco Vanhala, Antti Junkkari, Ville E. Korhonen, Mitja I. Kurki, Mikko Hiltunen, Tuomas Rauramaa, Ossi Nerg, Anne M. Koivisto, Anne M. Remes, Jonna Perälä, Jaana Suvisaari, Soili M. Lehto, Heimo Viinamäki, Hilkka Soininen, Juha E. Jääskeläinen, Ville Leinonen

PublisherWilliams & Wilkins Co.

Publication year2019

JournalNeurosurgery

Volume84

Issue4

First page 883

Last page889

Number of pages7

ISSN0148-396X

DOIhttps://doi.org/10.1093/neuros/nyy147

Web address https://academic.oup.com/neurosurgery/advance-article/doi/10.1093/neuros/nyy147/4993891

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/39492033


Abstract

BACKGROUND: Idiopathic normal pressure hydrocephalus (iNPH) is a progressive and potentially treatable neurodegenerative disease affecting elderly people, characterized by gait impairment and ventricular enlargement in brain imaging. Similar findings are seen in some patients with schizophrenia (SCZ).

OBJECTIVE: To determine the prevalence of SCZ among patients suffering from probable or possible iNPH and the specific effects of comorbid SCZ on the outcome of the cerebrospinal fluid (CSF) shunting.

METHODS: All medical records of the 521 iNPH patients in the NPH registry were retrospectively analyzed from 1991 until 2017. The prevalence of comorbidity of SCZ was determined and compared to that of general aged (≥65 yr) population in Finland.

RESULTS: We identified a total of 16 (3.1%) iNPH patients suffering from comorbid SCZ. The prevalence of SCZ among the iNPH patients was significantly higher compared to the general population (3.1% vs 0.9%, P < .001). All iNPH patients with comorbid SCZ were CSF shunted and 12 (75%) had a clinically verified shunt response 3 to 12 mo after the procedure. The CSF shunt response rate did not differ between patients with and without comorbid SCZ.

CONCLUSION: SCZ seems to occur 3 times more frequently among iNPH patients compared to the general aged population in Finland. The outcome of the treatment was not affected by comorbid SCZ and therefore iNPH patients suffering from comorbid SCZ should not be left untreated. These results merit validation in other populations. In addition, further research towards the potential connection between these chronic conditions is warranted.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 16:31